Industry: Pharmaceuticals (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2024-07-15 | New | $4,679,395 | $4,679,395 | Debt Only | 06b | SEC link |
2023-01-12 | Amended | $5,005,000 | $5,005,000 | Equity Only | 06b | SEC link |
2022-12-29 | New | $0 | $0 | Equity Only | 06b | SEC link |
2020-12-09 | New | $45,187,328 | $45,187,328 | Equity Only | 06b | SEC link |
2020-05-06 | New | $4,250,000 | $4,250,000 | Equity and Debt | 06b | SEC link |
Name | Role |
---|---|
Brent Ahrens | Director |
William Harrington, Md, Mba | Director |
Daniel Hetu, Md, Mba | Director |
Keith A. Katkin | Director |
John Pacifico | Director |
Dennis Podlesak | Director, Executive |
Lynne R. Rollins | Executive |
Brian Taylor Slingsby, Md, Phd, Mph | Director |
Eckard Weber, M.D. | Director, Executive |
Eckard Weber, Md | Director, Executive |